Healthcare News and Research

Latest Healthcare News and Research

Healthcare.gov still under construction

Though the website has been functioning for consumers buying insurance coverage, Politico reports that critical, back-end elements are still being built, which could have adverse effects on insurers and ultimately on next year's premiums.

29 Apr 2014

Intimate partner abuse before or during pregnancy linked to higher postpartum mental health problems

Ashley Pritchard, a Simon Fraser University doctoral student, is among four authors of a new research paper calling for closer monitoring of new mothers for mental health problems in light of their findings.

29 Apr 2014

Civitas reports positive results from CVT-301 Phase 2b trial for treatment of Parkinson's disease

Civitas Therapeutics, Inc., a privately-held pharmaceutical company developing and commercializing transformative therapeutics using its proprietary ARCUSTM technology, today announced positive results from a Phase 2b clinical trial of CVT-301, an inhaled formulation of levodopa (L-dopa).

29 Apr 2014

Democrats, GOP brace for 2016 health care fight

Democrats worry that talking about the health law will not net them any positive gains in elections this year. House Speaker John Boehner also took to the air Saturday to hammer President Obama on jobs and health care.

29 Apr 2014

Anaphylaxis Campaign's special conference to explore issues in allergy care

This special conference for our 20th Anniversary year will focus on providing a full and comprehensive round up of past, present and emerging themes and trends in allergy, care and management. The conference is free to all our Healthcare Professional Members and we are expecting over 70 clinicians in the field of allergy to attend.

29 Apr 2014

Oregon opts for federal exchange

The board overseeing Oregon's nonfunctional health insurance exchange unanimously approved the Obama administration's plan Friday to take over the marketplace, making Oregon the first state to drop its enrollment website for healthcare.gov.

29 Apr 2014

BRCA gene loss may accelerate cancer-promoting chromosome rearrangements

Inherited mutations in the BRCA1 or BRCA2 tumor suppressor genes are by far the most frequent contributors to hereditary cancer risk in the human population, often causing breast or ovarian cancer in young women of child-bearing age.

29 Apr 2014

GSK, Theravance announce availability of Anoro Ellipta in the US for COPD treatment

GlaxoSmithKline plc and Theravance, Inc. today announced that Anoro Ellipta (umeclidinium and vilanterol inhalation powder), the first once-daily product approved in the US that combines two long-acting bronchodilators in a single inhaler for the maintenance treatment of chronic obstructive pulmonary disease (COPD), is now available to retail pharmacies in the US.

28 Apr 2014

Truven Health Analytics announces acquisition of Fortel Analytics' healthcare fraud technology

Truven Health Analytics, a leading provider of healthcare analytics and data solutions and services, today announced the acquisition of Fortel Analytics' healthcare fraud technology. The acquisition gives Truven Health exclusive access to a breakthrough suite of predictive solutions, analysis methods and analytic technology designed to quickly identify suspicious patterns in healthcare insurance claims data before claims are ever paid.

28 Apr 2014

Monarch Medical Technologies gets FDA clearance for new glucose management solution

Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drugs and processes of concern in hospitalized patients, today announced the U.S. Food and Drug Administration clearance of its new glucose management solution, EndoTool IV.

28 Apr 2014

Australian and New Zealand patients with diabetes-induced vision loss to get access to new treatment

Australian and New Zealand patients suffering from vision impairment due to a type of diabetes-induced eye disease will have access to a new treatment, following a license deal between Australian biopharmaceutical company Specialised Therapeutics Australia and Alimera Sciences.

28 Apr 2014

First Edition: April 28, 2014

Today's headlines include a number of stories examining the impact of the health law in various states.

28 Apr 2014

Voluntis closes €20.75 million ($29 million) Series D financing round

Voluntis, a company pioneering therapeutic companion software, today announced the completion of its Series D financing round. With a total of €20.75 million ($29 million), this fund raising is one of the largest rounds of investment in the m-health sector this year.

28 Apr 2014

APCER Pharma's revenues grew by more than 40% in 2013

APCER Pharma, the truly global provider of strategic and outsourced services for clinical safety, pharmacovigilance, medical affairs, and regulatory operations, announced today that revenues grew by more than 40% in 2013 compared to the previous year.

28 Apr 2014

Researchers analyze patient satisfaction with pain treatment after surgery

An international research group with members from the University of Basel, several EU countries, Israel and the USA, analyzed patient satisfaction with pain treatment after surgery.

28 Apr 2014

Health care systems preparing to adapt University of Utah Health Care's online physician reviews

As other health care systems around the country prepare to follow in the footsteps of University of Utah Health Care —the first hospital system in the country to post online physician reviews and comments —Utah's only academic medical center is reporting new data about the innovative venture it launched in December 2012.

26 Apr 2014

Viewpoints: 'Pinocchios' for the Koch brothers; Obamacare 'miracle'; the law's effect on hiring

The health care ads being run by Americans for Prosperity - one of the many frantically waving arms of the Koch brothers - are a gift to fact checkers everywhere. Because they deliberately twist the truth to persuade people to "stop supporting Obamacare," they have become a machine for producing "Pinocchios," the mendacity rating system used by Glenn Kessler at The Washington Post (David Firestone, 4/24).

26 Apr 2014

Cover Oregon poised to join federal exchange

With encouragement from the Obama administration, an Oregon panel recommended Thursday that the state pull the plug on its glitch-ridden website and switch to the federal insurance marketplace. The final decision is expected to be made Friday by its exchange board. Oregon built what is widely regarded as the worst-functioning state exchange in the nation.

26 Apr 2014

European Commission approves VOKANAMET for treatment of adults with type 2 diabetes mellitus

Janssen-Cilag International NV (Janssen) announced today that the European Commission (EC) has approved VOKANAMET® (a fixed-dose therapy combining canagliflozin and immediate release metformin hydrochloride in a single tablet) in the European Union, for the treatment of adults with type 2 diabetes mellitus to improve glycaemic control.

26 Apr 2014

New data from EMD Serono's multiple sclerosis portfolio to be presented at the 66th AAN Annual Meeting

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that new data from the company's multiple sclerosis (MS) portfolio will be presented at the American Academy of Neurology's 66th Annual Meeting, taking place from April 26 – May 3, in Philadelphia, PA.

26 Apr 2014

Healthcare News and Research

Latest Healthcare News and Research

Healthcare.gov still under construction

Intimate partner abuse before or during pregnancy linked to higher postpartum mental health problems

Civitas reports positive results from CVT-301 Phase 2b trial for treatment of Parkinson's disease

Democrats, GOP brace for 2016 health care fight

Anaphylaxis Campaign's special conference to explore issues in allergy care

Oregon opts for federal exchange

BRCA gene loss may accelerate cancer-promoting chromosome rearrangements

GSK, Theravance announce availability of Anoro Ellipta in the US for COPD treatment

Truven Health Analytics announces acquisition of Fortel Analytics' healthcare fraud technology

Monarch Medical Technologies gets FDA clearance for new glucose management solution

Australian and New Zealand patients with diabetes-induced vision loss to get access to new treatment

First Edition: April 28, 2014

Voluntis closes €20.75 million ($29 million) Series D financing round

APCER Pharma's revenues grew by more than 40% in 2013

Researchers analyze patient satisfaction with pain treatment after surgery

Health care systems preparing to adapt University of Utah Health Care's online physician reviews

Viewpoints: 'Pinocchios' for the Koch brothers; Obamacare 'miracle'; the law's effect on hiring

Cover Oregon poised to join federal exchange

European Commission approves VOKANAMET for treatment of adults with type 2 diabetes mellitus

New data from EMD Serono's multiple sclerosis portfolio to be presented at the 66th AAN Annual Meeting

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Newsletters you may be interested in